Page 8 - பிராங்க்ஃபர்ட் ஸ்டாக் பரிமாற்றம் ப்ரைம் தரநிலை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பிராங்க்ஃபர்ட் ஸ்டாக் பரிமாற்றம் ப்ரைம் தரநிலை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பிராங்க்ஃபர்ட் ஸ்டாக் பரிமாற்றம் ப்ரைம் தரநிலை Today - Breaking & Trending Today

Biofrontera AG: Biofrontera AG announces the closing of the capital raise with gross proceeds of EUR 24.7 million

Business news for the stock market
Biofrontera AG: Biofrontera AG announces the closing of the capital raise with gross proceeds of EUR 24.7 million
Leverkusen (pta046/26.02.2021/15:20) - Leverkusen, Germany, February 26, 2021- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) ( Biofrontera or the Company ), an international biopharmaceutical company, announces the closing of the capital increase resolved by the annual general meeting on May 28, 2020.
The capital increase was carried out by way of a subscription rights offering to existing shareholders of Biofrontera AG under German law. Unsubscribed shares were placed in the course of a public offering of American Depositary Shares ( ADS and ADS Offering ) in the United States. The Company raised total gross proceeds of approximately EUR 24.7 million. ....

New York , United States , Pamela Keck , Thomas Schaffer , Quirin Privatbank , Hemmelrather Weg , Company Llc Capital , Federal Reserve Bank , Frankfurt Stock Exchange Prime Standard , Frankfurt Stock Exchange , Exchange Commission , Biofrontera Group , American Depositary Shares , Benchmark Company , Lake Street Capital Markets , Global Coordinator , European Bookrunner , Subscription Agent , Germany Telephone , Chief Financial Officer , Prime Standard , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , பமீலா கேக்க் , தாமஸ் ஶேஃபர் , நிறுவனம் லல்க் மூலதனம் ,

Investegate |PAION AG Announcements | PAION AG: PAION RECEIVES POSITIVE CHMP OPINION RECOMMENDING APPROVAL OF BYFAVO(R) (REMIMAZOLAM) IN PROCEDURAL SEDATION

DGAP-Ad-hoc: PAION AG / Key word(s): Miscellaneous
PAION RECEIVES POSITIVE CHMP OPINION RECOMMENDING APPROVAL OF BYFAVO(R) (REMIMAZOLAM) IN PROCEDURAL SEDATION
29-Jan-2021 / 11:20 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
PAION RECEIVES POSITIVE CHMP OPINION RECOMMENDING APPROVAL OF BYFAVO
(R) (REMIMAZOLAM) IN PROCEDURAL SEDATION
- Positive CHMP opinion based on the data from a comprehensive clinical program in procedural sedation in adult patients undergoing bronchoscopy or colonoscopy
- Final decision on MAA expected in the first half of 2021 ....

United Kingdom , South Korea , Yichang Humanwell , Hana Pharm , Ralf Penner , Jim Phillips , Specialty Pharma Company , European Medicines Agency , European Commission , Frankfurt Stock Exchange Prime Standard , Regulatory Agency , Distribution Services , Medicinal Products , Human Use , Marketing Authorization Application , European Economic Area , United Kingdom Medicines , Acacia Pharma , Southeast Asia , Regulatory Announcements , Corporate News , ஒன்றுபட்டது கிஂக்டம் , தெற்கு கொரியா , ஹனா பார்ம் , ரால்ஃப் பென்னர் , ஜிம் பிலிப்ஸ் ,

Investegate |PAION AG Announcements | PAION AG: ACACIA PHARMA LAUNCHES BYFAVO(TM) (REMIMAZOLAM) IN THE U.S. FOR PROCEDURAL SEDATION IN ADULTS UNDERGOING MEDICAL PROCEDURES LASTING 30 MINUTES OR LESS

PAION AG
ACACIA PHARMA LAUNCHES BYFAVO(TM) (REMIMAZOLAM) IN THE U.S. FOR PROCEDURAL SEDATION IN ADULTS UNDERGOING MEDICAL PROCEDURES LASTING 30 MINUTES OR LESS
DGAP-News: PAION AG
/ Key word(s): Product Launch
PAION AG: ACACIA PHARMA LAUNCHES BYFAVO(TM) (REMIMAZOLAM) IN THE U.S. FOR PROCEDURAL SEDATION IN ADULTS UNDERGOING MEDICAL PROCEDURES LASTING 30 MINUTES OR LESS
28.01.2021 / 07:06
The issuer is solely responsible for the content of this announcement.
PAION AG: ACACIA PHARMA LAUNCHES BYFAVO(TM) (REMIMAZOLAM) IN THE U.S. FOR PROCEDURAL SEDATION IN ADULTS UNDERGOING MEDICAL PROCEDURES LASTING 30 MINUTES OR LESS
- Approximately 40 million procedures take place annually in the U.S. that require the use of procedural sedation ....

South Korea , Mike Bolinder , Yichang Humanwell , Hana Pharm , Ralf Penner , Mckesson Medsurg , Jim Phillips , Us Drug Enforcement Administration , Specialty Pharma Company , Drug Administration , Frankfurt Stock Exchange Prime Standard , Cardinal Health , European Medicines Agency , Acacia Pharma , Enforcement Administration , Chief Executive Officer , Marketing Authorization Application , Southeast Asia , United Kingdom , Investegate Announcements , Investegate Company Announcements , Paion Ag , Eqs And , தெற்கு கொரியா , ஹனா பார்ம் , ரால்ஃப் பென்னர் ,

PAION AG: ACACIA PHARMA LAUNCHES BYFAVO(TM) (REMIMAZOLAM) IN THE U.S. FOR PROCEDURAL SEDATION IN ADULTS UNDERGOING MEDICAL PROCEDURES LASTING 30 MINUTES OR LESS

DGAP-News: PAION AG
/ Key word(s): Product Launch
PAION AG: ACACIA PHARMA LAUNCHES BYFAVO(TM) (REMIMAZOLAM) IN THE U.S. FOR PROCEDURAL SEDATION IN ADULTS UNDERGOING MEDICAL PROCEDURES LASTING 30 MINUTES OR LESS
28.01.2021 / 07:06
The issuer is solely responsible for the content of this announcement.
PAION AG: ACACIA PHARMA LAUNCHES BYFAVO(TM) (REMIMAZOLAM) IN THE U.S. FOR PROCEDURAL SEDATION IN ADULTS UNDERGOING MEDICAL PROCEDURES LASTING 30 MINUTES OR LESS
- Approximately 40 million procedures take place annually in the U.S. that require the use of procedural sedation
- BYFAVO(TM) is the second Acacia Pharma product approved and launched in the U.S. in the last year and extends its portfolio of new products targeting unmet needs in anesthesia ....

South Korea , Mike Bolinder , Yichang Humanwell , Hana Pharm , Ralf Penner , Mckesson Medsurg , Jim Phillips , Us Drug Enforcement Administration , Specialty Pharma Company , Drug Administration , Frankfurt Stock Exchange Prime Standard , Cardinal Health , European Medicines Agency , Acacia Pharma , Enforcement Administration , Chief Executive Officer , Marketing Authorization Application , Southeast Asia , United Kingdom , Paion Ag Stock Exchange , Press Release , Medi Cal , Minutes Pa8 De000a0b65s3 , தெற்கு கொரியா , ஹனா பார்ம் , ரால்ஃப் பென்னர் ,

SHOP APOTHEKE EUROPE: Pooling agreement of several shareholders with voting agreement for more than 26% of the voting rights.

Nachricht vom 28.01.2021 | 13:26
SHOP APOTHEKE EUROPE: Pooling agreement of several shareholders with voting agreement for more than 26% of the voting rights.
SHOP APOTHEKE EUROPE N.V. / Key word(s): Miscellaneous
SHOP APOTHEKE EUROPE: Pooling agreement of several shareholders with voting agreement for more than 26% of the voting rights.
28-Jan-2021 / 13:26 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
SHOP APOTHEKE EUROPE: Pooling agreement of several shareholders with voting agreement for more than 26% of the voting rights ....

Sven Schirmer , Apotheek Venlo , Thomas Schnorrenberg , Carmen Herkenrath , Frankfurt Stock Exchange Prime Standard , Distribution Services , Supervisory Board , Europa Apotheek Venlo , Frankfurt Stock Exchange , Prime Standard , Regulatory Announcements , Corporate News , ஸ்வெந் ஸ்கிர்மர் , பிராங்க்ஃபர்ட் ஸ்டாக் பரிமாற்றம் ப்ரைம் தரநிலை , விநியோகம் சேவைகள் , மேற்பார்வை பலகை , பிராங்க்ஃபர்ட் ஸ்டாக் பரிமாற்றம் , ப்ரைம் தரநிலை , ஒழுங்குமுறை அறிவிப்புகள் , பெருநிறுவன செய்தி ,